5 December 2016 11:23 by Sam Davies

The 3D pancreas model used felxible Poly Lactic Acid material scaffold and adult human pancreatic stem cells.by Sam Davies

Since its foundation in 2002, Celprogen Inc has been committed to proficient research in the stem cell field.Celprogen Inc, a leader in the Stem Cell Research and Therapeutics industry since 2002, have successfully finished printing a 3D pancreas model from flexible Poly Lactic Acid (PLA) material scaffold.The PLA material was populated with adult human pancreatic stem cells, meaning the 3D-printed pancreas should function like a real-life organ. Three T225 human pancreatic stem cells 36097-24-T225, along with human adult pancreatic cells 3002-04-T225 were used to coat the pancreas, while the scaffold was coated with Extracellular Matrix (ECM) prior to seeding the cells.

This flexible PLA scaffold allows the seeded pancreatic stem cells to potentially develop into working pancreas. The 3D-printed organ was reduced from an adult, 18-year-old pancreas to roughly a fifth of its original size.Celprogen’s most recent development relates to 3D organ printing programmes at the company that identify potential future use in transplants of major organ systems. Currently, Celprogen is validating a 3D human printed heart from flexible PLA, as well as the pancreas. Their 3D heart model will be presented at the American Society of Cell Biology Annual Meeting this week in San Francisco, California. The 3D-printed heart is being utilised as a model for screening potential drug candidates for cardiac toxicity.

Since its foundation in 2002, Celprogen Inc has been committed to proficient research in the stem cell field. Over the last 14 years, it has developed a proprietary portfolio of unique therapeutics products and life science research tools that includes genetic engineering technologies, stem cell technologies for regenerative medicine, as well as bio-engineering products for tissue and organ transplants.

Headquartered in Torrance, California Celprogen aims to continue their work in the Stem Cell Research and Therapeutics field. It strives to research, develop and manufacture quality Stem Cell, Cancer Stem Cell and Primary Cell Culture products to serve people around the world.

To read further, click here

Contacts

For additional information on the product line contact:
Celprogen Inc.
Jay Sharma
310-542-8822
info@celprogen.com